Retroperitoneal schwannoma mimicking metastatic seminoma: case report and literature review.
- Author:
Shi-Qiang ZHANG
1
;
Song WU
;
Kai YAO
;
Pei DONG
;
Yong-Hong LI
;
Zhi-Ling ZHANG
;
Xian-Xin LI
;
Fang-Jian ZHOU
Author Information
- Publication Type:Case Reports
- MeSH: Adult; Antibiotics, Antineoplastic; therapeutic use; Antineoplastic Agents; therapeutic use; Antineoplastic Agents, Phytogenic; therapeutic use; Bleomycin; therapeutic use; Cisplatin; therapeutic use; Diagnostic Errors; Etoposide; therapeutic use; Humans; Lymph Node Excision; Lymph Nodes; pathology; Lymphatic Metastasis; Male; Neoplasms, Multiple Primary; Neurilemmoma; diagnostic imaging; drug therapy; pathology; Radiography; Retroperitoneal Neoplasms; diagnostic imaging; drug therapy; pathology; secondary; Retroperitoneal Space; Seminoma; secondary; surgery; Testicular Neoplasms; surgery
- From:Chinese Journal of Cancer 2013;32(3):149-152
- CountryChina
- Language:English
- Abstract: If a testicular cancer patient has a mass in the retroperitoneum, a metastasis is often the first suspicion, probably leading to improper diagnosis and overtreatment. Here we report a case of retroperitoneal schwannoma mimicking metastatic seminoma. A 29-year-old man, who had a history of seminoma, presented with a single retroperitoneal mass suspected to be a metastasis. Because the patient refused radiotherapy, 3 cycles of cisplatin, etoposide, and bleomycin were offered. Post-chemotherapy computed tomography scan revealed persistence of the retroperitoneal mass, with no change in tumor size or characteristics. Subsequently, retroperitoneal lymph node dissection was performed. The dissected tissue contained negative lymph nodes but a single mass in the attached fat. Pathology revealed retroperitoneal schwannoma, which was confirmed by immunohistochemistry. Thus, clinicians should be aware of retroperitoneal schwannoma and its distinction from metastatic seminoma to avoid misdiagnosis and ensure proper treatment.
